8-K ·Filed Apr 23, 2026

GPRE

Green Plains Inc.
NEUTRAL
Impact 4/10
Horizonweeks Processed5mo ago SEC0001309402-26-000045
8-K material event: Items 1.01
Actionable Insight • Neutral

Monitor the company's liquidity utilization and future financing activities, as the reduced commitment may indicate more conservative capital management or reduced near-term funding needs. The extension suggests improved lender confidence despite the smaller facility size.

DirectionNeutral
Confidencehigh
Horizonweeks
Final — all horizons settled through T+60d
GPRE ▲ +10.99% at T+60d
NEUTRAL call ✓ call won +10.99% · α vs SPY +5.91% · entry $15.92 → $17.67
Entry anchored
Apr 23, 03:59 PM ET
via exchange tick
T+1d
+3.39%
call +3.39% · α +3.23%
$16.46
settled 5mo ago
T+5d
+9.17%
call +9.17% · α +8.26%
$17.38
settled 5mo ago
T+20d
-5.34%
call -5.34% · α -9.37%
$15.07
settled 4mo ago
T+60d
+10.99%
call +10.99% · α +5.91%
$17.67
settled 2mo ago

Price Chart

Loading chart...

Executive Summary

Green Plains Inc. amended its senior secured revolving credit facility, reducing the commitment from $350 million to $300 million while extending the maturity date from March 25, 2027 to September 25, 2027. The company continues to maintain its sustainability-linked loan structure with a syndicate of lenders led by ING Capital LLC.

Key Financial Metrics

Deal Value
$300.0M
Deal Type
credit_facility

Key Facts

  • Revolving loan commitment reduced from $350 million to $300 million
  • Maturity date extended by six months from March 25, 2027 to September 25, 2027
  • Amendment effective April 17, 2026
  • Lender syndicate includes ING Capital LLC, PNC Bank, Fifth Third Bank, Bank of America, BMO Bank, First Horizon Bank, CoBank, Farm Credit Services of America, and Macquarie Bank Limited
  • Facility remains sustainability-linked

Financial Impact

Reduces available liquidity by $50 million while providing six-month maturity extension

debtliquiditycovenants

Risk Factors

  • Reduced liquidity could constrain operational flexibility if market conditions worsen
  • Potential signal of reduced growth capital availability or strategic downsizing

Market Snapshot

Exchange
Nasdaq
Sector
Industrial Organic Chemicals

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 5 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001309402-26-000045
Document: gpre-20260417.htm0001309402-26-000045
Document: 0001309402-26-000045-index-headers.html0001309402-26-000045
Document: 0001309402-26-000045-index.html0001309402-26-000045
Document: 0001309402-26-000045.txt0001309402-26-000045
5 reports for GPRE
Performance horizon
Filters
Rows
Reports for GPRE — sortable, filterable
TypeNow
Aug 6, 2026
8w ago
8-K
MIXED ★ 5/10
$15.20 $14.96▼ −1.58%▼ −2.18%$15.23 (+0.20%)
Jun 22, 2026
14w ago
S-3ASR
NEUTRAL ★ 4/10
$14.41 $16.83▲ +16.79%▲ +15.63%$15.23 (+5.69%)
May 7, 2026
21w ago
8-K
MIXED ★ 7/10
$16.46 $15.90▼ −3.40%▼ −6.54%$15.23 (−7.47%)
Apr 24, 2026
23w ago
DEFA14A
NEUTRAL ★ 3/10
$16.46 $15.83▼ −3.83%▼ −8.78%$15.23 (−7.47%)
Apr 23, 2026
23w ago
8-K
NEUTRAL ★ 4/10
$15.92 $15.07▼ −5.34%▼ −9.37%$15.23 (−4.33%)
Showing 5 of 5

US Market Status

Market Closed — Opens Mon (38h 7m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Try SecBot Free Coming soon: SecBot Pro with alerts, watchlists, and API access